about els els technology ELS ppl ELS careers address & phone number

Donal O'Dwyer, Chairman

Donal is an innovative, growth-driven top management executive and corporate officer with P&L responsibility and extensive worldwide experience in healthcare products, medical devices in sales and marketing, product development and manufacturing operations. Possesses a proven ability to capture market leadership, dramatically expand global footprint, introduce novel technologies and consistently increase sales and maximize profit. Combines excellent communication and problem-solving skills to optimize company’s performance and image and attract top achievers to the organization. He approaches each new challenge with a contagious desire for success. Recent job assignments includes holding the position of Worldwide President of Cordis Corp., a Johnson & Johnson Company and Director of Sales and Marketing, Cardiovascular Group President of Baxter Healthcare.

 

Ashish Mitra, Founder, CEO and Chief Technology Officer (CTO)

Ashish Mitra has completed his post graduate training in Mechanical Engineering at Stanford University, with specialization in BioDesign (Medical Devices), Product Design and Design for Manufacturability. Passionate about medical device engineering he has developed technical expertise in the field of aortic, cardiac and peripheral vascular stent technologies at the Research and Development Groups of Medtronic Vascular, Santa Rosa, CA and Medtronic Structural Heart Disease, Santa Ana, CA. His experience spans the full spectrum of medical technology development from conception to successful PMA approvals. A creative inventor, he has an expanding IP portfolio having received several recognitions including awards from the J.F. Lincoln Foundation and the Indian National Academy of Engineers. He also has a keen didactic inclination and is currently serving as an Honorary Associate and Lecturer at the Biomedical Engineering Department, University of Sydney, Australia.

 

 

Dr. Martin Ng, Founder and Chief Medical Officer (CMO)

Dr. Martin Ng, MD PhD, is an interventional cardiologist who has completed his fellowship training at Stanford University Medical Centre. Originally from Australia, he graduated with First Class Honours in Medicine from the University of Sydney prior to completing a PhD on the molecular biology of early coronary artery disease. His research has garnered numerous awards and honours including the Royal Australasian College of Physicians' Young Investigator of the Year in 2001 and selection to the American Heart Association Late- Breaking Basic Sciences Sessions for innovative, important and novel science in 2002. Dr Ng's core long term interests are focussed on bench-to-bedside innovation within interventional cardiology, including therapeutic angiogenesis and novel cardiovascular device related treatments for atherosclerosis.

 

 

Brigitte Smith, Director

Brigitte Smith has twenty years’ experience in venture capital, business strategy and start-up company operations. Brigitte has been investing and managing investments for GBS’s $450m of life science specialised venture capital funds since 1998. Brigitte is on the board of GBS portfolio companies AirXpanders Inc, Endoluminal Sciences Pty Ltd, Neuromonics Pty Ltd, Proacta Inc, and Vivive Inc. Brigitte was the founding investor and chair of Pharmaxis Pty Ltd. Prior to founding GBS Brigitte worked in the US and Australia in operating roles with early stage technology based companies, and at Bain & Company as a strategic management consultant. Ms Smith has a B. Chem Eng (Honours) from the University of Melbourne, and as a Fulbright Scholar completed a MBA (Honours) from the Harvard Business School and a MALD from the Fletcher School of Law and Diplomacy, both in Boston, USA.